comparemela.com

Latest Breaking News On - Cancer therapy advisor - Page 11 : comparemela.com

1 in 20 Gynecologic Cancer Patients Die Within 30 Days of COVID-19 Diagnosis

Patients with gynecologic cancers may have a high risk of hospitalization and death from COVID-19, according to registry data.

Mayo clinic in rochesterUnited statesNew yorkGretchen glaserSociety of gynecologic oncologyCancer therapy advisorMayo clinicGynecologic oncologyGynecologic cancer

Black, Hispanic Patients Underrepresented in Trials Supporting Guidelines for Endometrial Cancer

Black and Hispanic patients are underrepresented in the clinical trials used to develop the NCCN treatment guidelines for endometrial cancer.

New yorkUnited statesNamita kulkarniColumbia university irving medical centerUs centers for diseaseNational comprehensive cancer networkCancer therapy advisorPractice guidelinesDisease control

Olaparib Did Not Improve PFS2, OS in SOLO3 Trial

Olaparib did not improve overall survival or the time from randomization to second progression or death, when compared with chemotherapy.

United statesSutro biopharmaRichard pensonWiley blackwellRoche pharmaWolters kluwer healthArray biopharma incVascular biogenics ltdTesaro incEisai incMerck coGenentech incElsevier ltdCancer therapy advisorMassachusetts general hospitalCancer panels

Alarming Trend in Uterine Cancer Incidence: High-Risk Histologies on the Rise

The incidence of high-risk uterine cancer is increasing in the United States, particularly among Black patients, a large study suggests.

United statesLos angelesCortney eakinUniversity of californiaCancer therapy advisorUnited states cancer statisticsBehavioral risk factors surveillance system

Tool Predicts Need for Blood Transfusion Due to Ovarian Cancer Surgery

A new tool can predict the need for blood transfusion due to primary debulking surgery in patients with ovarian cancer, according to researchers.

New yorkUnited statesMemorial sloan kettering cancer centerBryan kahnAmerican society of anesthesiologistsCancer therapy advisor

vimarsana © 2020. All Rights Reserved.